These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 23124496

  • 21. The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial.
    Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Stranne J, Hugosson J.
    Eur J Cancer; 2011 Mar; 47(4):545-53. PubMed ID: 21087857
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men.
    Tang P, Sun L, Uhlman MA, Robertson CN, Polascik TJ, Moul JW.
    BJU Int; 2011 Jul; 108(1):44-8. PubMed ID: 21050357
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening.
    Gattellari M, Ward JE.
    Patient Educ Couns; 2005 May; 57(2):168-82. PubMed ID: 15911190
    [Abstract] [Full Text] [Related]

  • 28. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet.
    Wilt TJ, Paul J, Murdoch M, Nelson D, Nugent S, Rubins HB.
    Eff Clin Pract; 2001 May; 4(3):112-20. PubMed ID: 11434074
    [Abstract] [Full Text] [Related]

  • 29. Development and pilot testing of an online screening decision aid for men with a family history of prostate cancer.
    Wakefield CE, Watts KJ, Meiser B, Sansom-Daly U, Barratt A, Mann GJ, Lobb EA, Gaff CL, Howard K, Patel MI.
    Patient Educ Couns; 2011 Apr; 83(1):64-72. PubMed ID: 20580521
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50".
    Andriole GL, Kibel AS.
    Cancer; 2011 Mar 15; 117(6):1110-2. PubMed ID: 20960524
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Re: decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial.
    Taneja SS.
    J Urol; 2014 May 15; 191(5):1286-7. PubMed ID: 24745485
    [No Abstract] [Full Text] [Related]

  • 37. Prostate cancer screening in a Saudi population: an explanatory trial study.
    Rabah DM, Arafa MA.
    Prostate Cancer Prostatic Dis; 2010 Jun 15; 13(2):191-4. PubMed ID: 20066007
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.